First U.S. Study Assesses Vaccine Efficacy
In a groundbreaking study, the Centers for Disease Control and Prevention (CDC) revealed that the latest versions of COVID-19 vaccines are 54% effective in preventing symptomatic infection among adults. This study is the first of its kind in the United States, providing crucial insights into the efficacy of these vaccines.
Promising Results Against Recent Coronavirus Variants
Developed to offer improved protection against more recent coronavirus variants, the vaccines have shown similar efficacy rates in other countries. The CDC’s study examined a sample size of 9,000 individuals who underwent COVID-19 testing at CVS and Walgreens pharmacies. The researchers analyzed whether these individuals tested positive and whether they had received a recent vaccine.
Comparable Results to Earlier Vaccine Version
The findings of the study, led by CDC’s Ruth Link-Gelles, align with previously reported data on vaccine efficacy. The 54% effectiveness is on par with earlier versions of the vaccine. However, it is important to note that this study specifically focused on symptomatic infection prevention.
Future Studies to Assess Vaccine Effectiveness
In the coming months, additional studies will evaluate the vaccine’s ability to prevent severe symptoms that require medical attention or hospitalization. This data will provide further insights into the overall effectiveness of the vaccine in the fight against COVID-19.
Low Vaccination Rates Pose Challenges
Despite the CDC’s recommendation to administer the new shots to individuals aged 6 months and older, the majority of Americans have not received the vaccines. According to the latest CDC data, only approximately 22% of U.S. adults and a mere 11% of children have been vaccinated. This slow uptake has resulted in a longer timeline for researchers to gather sufficient data on vaccine efficacy.
Note: The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group. The AP is solely responsible for all content.
